Scroll
To Top
Menu
Home / Resources

Resources and Materials

What is Patient Focused Drug Development (PFDD)?
How Will RDCA-DAP® Support Patient Focused Drug Development?
Sharing Data With RDCA-DAP: Your Questions Answered
How Patient Nonprofits Can Help Accelerate Drug Development
RDCA-DAP® Data Collaboration Center Graphic
What You Need to Know About the Rare Disease Cures Accelerator-Data and Analytics Platform
Accelerating Rare Disease Drug Development: The Drug Development Process
Accelerating Rare Disease Drug Development: Rare Disease Challenges in Each Step of the Drug Development Process.
Accelerating Rare Disease Drug Development: RDCA-DAP - Shortening the Timeline for Developing New Treatments for Rare Diseases
Why is it important to your organization to be involved with RDCA-DAP®?
How Does Data Sharing Improve the Understanding of Rare Diseases?
How Can Patients and Advocates Help Accelerate Drug Development?
RDCA-DAP® Launch Live Stream - AM Part 1
Shortening the Timeline for Developing New Treatments - How the RDCA-DAP® Can Help
From Data To Cures: Speeding The Way For Rare Diseases
5 Steps to Drug Development Brochure
RDCA-DAP® Icongraphic
Program/Agenda: Rare Disease Cures Accelerator-Data and Analytics Platform Launch
RDCA: What is it and What are its Core Components?
Current Challenges in Rare Disease Drug Development
Accelerating Drug Development for Rare Diseases
NORD Registry Presentation
C-Path Data Integration and Analytics Approaches

*RDCA-DAP® is fully funded with a federal grant awarded to the Critical Path Institute.

Alone we are rare. Together we are strong.®